These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6856656)

  • 1. Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations in the rat.
    Sgaragli GP; Della Corte L; Gremigni D
    Pharmacol Res Commun; 1983 Mar; 15(3):231-46. PubMed ID: 6856656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorimipramine-induced phospholipidosis: biochemical and pharmacokinetic observations [proceedings].
    Della Corte L; Gremigni D; Megazzini I; Mobilio R; Sgaragli GP
    Br J Pharmacol; 1979 Nov; 67(3):449P-450P. PubMed ID: 497566
    [No Abstract]   [Full Text] [Related]  

  • 3. [Phospholipidosis of the rat lung following administrations of chlorimipramine].
    Gremigni D; Vannelli G; Sgaragli G; Della Corte L
    Arch Ital Anat Embriol; 1981; 86(1-2):37-53. PubMed ID: 7316635
    [No Abstract]   [Full Text] [Related]  

  • 4. Tissue distribution of chlorimipramine and its demethylated metabolite after a single dose in the rat.
    Della Corte L; Sgaragli GP
    Pharmacol Res Commun; 1984 Feb; 16(2):207-13. PubMed ID: 6504970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: role of tissue and species in manifestation of toxicity.
    Kacew S
    J Pharmacol Exp Ther; 1985 Jan; 232(1):239-43. PubMed ID: 3965695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phospholipidosis induced by chlorimipramine in rat lung].
    Gremigni D; Vannelli G; Sgaragli GP; Mengazzini I
    Boll Soc Ital Biol Sper; 1980 May; 56(10):1078-82. PubMed ID: 7448010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat tissue concentrations of chlorimipramine, chlorpromazine and their N-demethylated metabolites after a single oral dose of the parent compounds.
    Sgaragli GP; Valoti M; Palmi M; Frosini M; Giovannini MG; Bianchi L; Della Corte L
    J Pharm Pharmacol; 1995 Sep; 47(9):782-90. PubMed ID: 8583393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological, histochemical and biochemical changes induced by homochlorcyclizine in the rat].
    Lageron A; Saffroy M
    Acta Histochem; 1982; 71(1):103-10. PubMed ID: 6128854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorcyclizine--induced pulmonary phospholipidosis in rats.
    Reasor MJ; Heyneman CA; Walker ER
    Res Commun Chem Pathol Pharmacol; 1982 Nov; 38(2):235-46. PubMed ID: 6131507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiodarone induced phospholipidosis. Biochemical, morphological and functional changes in the lungs of rats chronically treated with amiodarone.
    Riva E; Marchi S; Pesenti A; Bizzi A; Cini M; Veneroni E; Tavbani E; Boeri R; Bertani T; Latini R
    Biochem Pharmacol; 1987 Oct; 36(19):3209-14. PubMed ID: 3663236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible, hepatic, lysosomal phospholipidosis in rat induced by subchronic daily administration of trospectomycin sulfate.
    Cox JW; Ulrich RG; Wynalda MA; McKenna R; Larsen ER; Ginsberg LC; Epps DE
    Biochem Pharmacol; 1989 Oct; 38(20):3535-41. PubMed ID: 2530987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochemical demonstration of increased phospholipid content in cell membranes in chlorphentermine-induced phospholipidosis.
    Coulombe PA; Bendayan M
    J Histochem Cytochem; 1989 Feb; 37(2):139-47. PubMed ID: 2911004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats.
    Reasor MJ; McCloud CM; Beard TL; Ebert DC; Kacew S; Gardner MF; Aldern KA; Hostetler KY
    Toxicology; 1996 Jan; 106(1-3):139-47. PubMed ID: 8571385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead-induced phospholipidosis and cholesterogenesis in rat tissues.
    Ademuyiwa O; Agarwal R; Chandra R; Behari JR
    Chem Biol Interact; 2009 May; 179(2-3):314-20. PubMed ID: 19056365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers to monitor drug-induced phospholipidosis.
    Baronas ET; Lee JW; Alden C; Hsieh FY
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):72-8. PubMed ID: 17156806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled cationic amphiphilic drug-induced pulmonary phospholipidosis in rats and dogs: time-course and dose-response of biomarkers of exposure and effect.
    Pauluhn J
    Toxicology; 2005 Feb; 207(1):59-72. PubMed ID: 15590122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs.
    Ohmiya Y; Angevine LS; Mehendale HM
    Drug Metab Dispos; 1983; 11(1):25-30. PubMed ID: 6132791
    [No Abstract]   [Full Text] [Related]  

  • 18. Amiodarone toxicity. II. Desethylamiodarone-induced phospholipidosis and ultrastructural changes during repeated administration in rats.
    Kannan R; Sarma JS; Guha M; Venkataraman K
    Fundam Appl Toxicol; 1991 Jan; 16(1):103-9. PubMed ID: 2019335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strategy for risk management of drug-induced phospholipidosis.
    Chatman LA; Morton D; Johnson TO; Anway SD
    Toxicol Pathol; 2009 Dec; 37(7):997-1005. PubMed ID: 20008549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of chlorimipramine and its demethylated metabolite in blood and brain regions of rats treated acutely and chronically with chlorimipramine.
    Friedman E; Cooper TB
    J Pharmacol Exp Ther; 1983 May; 225(2):387-90. PubMed ID: 6842401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.